Amarin Corporation PLC (NASDAQ:AMRN)

6.84
Delayed Data
As of 4:00pm ET
 +0.12 / +1.79%
Today’s Change
3.95
Today|||52-Week Range
26.12
-68.10%
Year-to-Date
FDA Approves Generic Version of Amarin's Blockbuster Fish Oil Capsules
May 22 / MotleyFool.com - Paid Partner Content
1 Biotech Stock to Avoid at All Costs
May 22 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close6.72
Today’s open6.72
Day’s range6.58 - 6.88
Volume324,258
Average volume (3 months)12,879,465
Market cap$2.6B
Data as of 4:00pm ET, 06/02/2020

Growth & Valuation

Earnings growth (last year)+83.02%
Earnings growth (this year)-53.19%
Earnings growth (next 5 years)+42.30%
Revenue growth (last year)+88.59%
P/E ratioNM
Price/Sales17.02
Price/Book4.21

Competitors

 Today’s
change
Today’s
% change
FGENFibroGen Inc+0.30+0.89%
MEDPMedpace Holdings Inc+0.82+0.91%
--Oxford BioMedica PLC+0.20+2.27%
DBVTDBV Technologies SA+0.08+1.64%
Data as of 4:00pm ET, 06/02/2020

Financials

Next reporting dateJuly 29, 2020
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$431.5M
Annual profit (last year)-$22.7M
Net profit margin-5.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
No executives to display
Corporate headquarters
Dublin, Dublin

Forecasts